论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
根据患者和观察者疤痕评估量表评估等离子皮肤再生联合放射治疗瘢痕疙瘩
Authors Ting W, Chong Y, Xu J, Huang J, Yu N, Liu Z
Received 22 May 2021
Accepted for publication 21 July 2021
Published 5 August 2021 Volume 2021:14 Pages 981—989
DOI https://doi.org/10.2147/CCID.S321348
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jeffrey Weinberg
Purpose: Keloids are caused by uncontrolled excessive proliferation of fibrous tissue. Multiple treatment strategies including steroid injection, surgical excision, laser therapy and radiation therapy have been reported. Few studies have evaluated the performance of plasma skin regeneration (PSR) in the treatment of keloid. This study aimed to evaluate the effectiveness of PSR combined with radiation therapy for keloids on different body parts.
Patients and Methods: A total of 71 patients with 98 keloids were enrolled in this study. Keloids < 4 mm thick underwent single-dose PSR, while keloids ≥ 4 mm thick were administered compound betamethasone injection beforehand. Radiation therapy was administered after 24 hours and again 7 days later after PSR. The outcome was evaluated using the patient and observer scar assessment scale at 12 months post-treatment.
Results: Patient-reported average scores for all keloids significantly decreased from 35.05± 9.94 to 21.84± 7.04 (p < 0.05). Keloids on face and neck, chest, and back responded better than those on shoulders and limbs. The recurrence rate was observed to be 15.3% (15 out of 98). Adverse effects were mild.
Conclusion: PSR combined with radiation therapy is an effective and safe strategy to treat keloids. Location could be a factor that affects curative effects.
Keywords: keloid, plasma skin regeneration, radiation therapy, POSAS, recurrence rate